Out-of-Pocket Costs for Chronic Illness Management in High-Deductible Health Plans
JAMA Network Open · 2026
DOI: 10.1001/jamanetworkopen.2026.38780 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2026. Verfasst von Risha Gidwani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Care Policy and Research, University of Colorado School of Medicine, Aurora. Hauptthemen laut MEDLINE: Deductibles and Coinsurance, Health Expenditures. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Importance High-deductible health plans (HDHPs) enroll a substantial share of privately insured Americans and are associated with reduced use of care, even care that is considered medically necessary. However, the magnitude of patient out-of-pocket (OOP) costs required to obtain evidence-based medical care when enrolled in HDHPs remains poorly understood.
Objective
To estimate patient OOP costs required to receive guideline-concordant care for common chronic conditions when enrolled in an HDHP vs a non-HDHP. Design, Setting, and Participants This retrospective cohort study used 2022 to 2023 national commercial insurance claims data. Participants included adults aged 18 to 64 years with employer-sponsored insurance and previously diagnosed diabetes, hypertension, or both. To enter the cohort, persons had to have received guideline-concordant care for their chronic illnesses. Data were analyzed from July 2025 to April 2026. Exposure Enrollment in an HDHP vs a non-HDHP. Main Outcomes and Measures The primary outcome was annual patient OOP costs to receive evidence-based care. Entropy balancing and generalized linear models with geographic fixed effects estimated the mean OOP costs of receiving minimum recommended medical care for diabetes, hypertension, or both in HDHPs and non-HDHPs. Estimates were weighted to ensure that observed costs were representative of the full sample of chronically ill persons.
Results
There were 539 590 adults receiving guideline-concordant care who entered the cohort. After entropy balancing, groups exhibited mean covariate balance, with males representing 57.9% of HDHP enrollees and 57.8% of non-HDHP enrollees, and similar age distributions across groups, with 45.4% of both HDHP and non-HDHP enrollees 55 to 64 years of age. The estimated annual OOP cost for individuals to receive guideline-concordant diabetes care was $153.91 (95% CI, $150.18-$157.64) in HDHPs vs $68.06 (95% CI, $66.34-$69.78) in non-HDHPs; $128.94 (95% CI, $127.25-$130.64) in HDHPs vs $53.89 (95% CI, $53.20-$54.58) in non-HDHPs for guideline-concordant hypertension care; and $164.18 (95% CI, $160.93-$167.44) in HDHPs vs $100.60 (95% CI, $98.80-$102.39) in non-HDHPs for guideline-concordant care for comorbid diabetes and hypertension (all P < .001). Conclusions and Relevance In this cohort study of a large, national sample of chronically ill adults with hypertension, diabetes, or both, annual patient costs were 1.6 to 2.4 times as high to receive recommended care in HDHPs vs non-HDHPs, although the magnitude of the difference in OOP costs was relatively small (range, $63.68 to $85.85). Findings provide novel evidence quantifying the magnitude of cost burden experienced by chronically ill patients under various insurance mechanisms and complement prior HDHP studies evaluating health care utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Health Care Policy and Research, University of Colorado School of Medicine, Aurora.
- RAND Corporation, Santa Monica, California.
- Department of Health Policy and Management, University of California, Los Angeles.
- Department of Health Systems, Management and Policy, Colorado School of Public Health, Aurora.
- Department of Economics, University of Southern California, Los Angeles.
- Division of Primary Care and Population Health, Stanford University, Palo Alto, California.
Förderung
- NIA NIH HHS
Zitieren
APA
Gidwani, R., Wagner, Z., Asch, S. M., Yank, V., & Burgette, L. (2026). Out-of-Pocket Costs for Chronic Illness Management in High-Deductible Health Plans. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.38780
Vancouver
Gidwani R, Wagner Z, Asch SM, Yank V, Burgette L. Out-of-Pocket Costs for Chronic Illness Management in High-Deductible Health Plans. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2026.38780
BibTeX
@article{Gidwani2026,
author = {Gidwani, Risha and Wagner, Zachary and Asch, Steven M and Yank, Veronica and Burgette, Lane},
title = {Out-of-Pocket Costs for Chronic Illness Management in High-Deductible Health Plans},
journal = {JAMA Network Open},
year = {2026},
doi = {10.1001/jamanetworkopen.2026.38780}
}
EUVIMED